We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 11-Oct-2022 / 14:01 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...
Norges Bank - Form 8.3 - Nektar Therapeutics, Inc PR Newswire London, October 11 ...
L FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1...
L FORM 8.3 OPENING DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 10-Oct-2022 / 14:21 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 47.18 | 47.18 | 47.18 | 4581 | 47.18 | DE |
4 | 0 | 0 | 47.18 | 47.18 | 47.18 | 17821 | 47.18 | DE |
12 | 0 | 0 | 47.18 | 47.18 | 47.18 | 9889 | 47.18 | DE |
26 | 0 | 0 | 47.18 | 47.18 | 47.18 | 7228 | 47.18 | DE |
52 | 0 | 0 | 47.18 | 47.18 | 47.18 | 9474 | 47.18 | DE |
156 | 0 | 0 | 47.18 | 47.18 | 47.18 | 6915 | 47.18 | DE |
260 | 0 | 0 | 47.18 | 47.18 | 47.18 | 4261 | 47.18 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions